Adipose tissue plays a crucial role in the body, serving as an energy reserve, producing hormones, and regulating metabolism. In the past, fat tissue was thought to be useless, but modern research shows that it is an active and essential organ.

Excess fat accumulation is linked to a higher risk of developing diabetes, cardiovascular diseases, and other health problems. However, a deficiency or abnormal distribution of fat tissue, which can occur in rare genetic and autoimmune conditions such as familial partial lipodystrophy type 2 (FPLD2), can also lead to diabetes and other metabolic disorders.

Research dedicated to these disorders aims to uncover why pathological fat loss disrupts metabolism and to find new treatment methods for patients with lipodystrophic syndromes. To study these processes, scientists have developed a mouse model in which the lamin A/C gene can be deactivated in adipocytes—the same gene that mutates in people with FPLD2.

Experiments revealed significant changes in gene activity that hinder the normal processing and storage of lipids by fat cells. At the same time, both adipocytes and immune cells within the fat tissue entered a pro-inflammatory state, and the mitochondria in fat cells lost their ability to function properly. Since mitochondria supply cells with energy, their dysfunction can have serious health consequences.

These changes create conditions where fat tissue becomes unhealthy and gradually disappears. When healthy adipose tissue is lost, the body loses its ability to manage lipids and secrete essential metabolic hormones, which can result in severe conditions such as diabetes and fatty liver disease.

The study highlights the importance of maintaining healthy fat tissue for proper metabolism. Type 2 diabetes has traditionally been associated with dysfunction of pancreatic beta cells that produce insulin, but new evidence points to a significant role for fat cells in maintaining normal blood sugar levels and overall metabolic health.

Researchers are exploring the possibility of developing new therapeutic approaches aimed at protecting adipose tissue before it is destroyed, in order to prevent the loss of fat cells and reduce the metabolic damage caused by disease.

This work also demonstrates the value of collaboration between laboratory scientists, clinicians, and patients, as well as the importance of patient involvement in therapy development and in understanding the unique aspects of their condition.